AI breakthrough could spot breast cancer early without risky dye
NCT ID NCT07205276
Summary
This study aims to develop an artificial intelligence (AI) tool that can detect breast cancer early using standard MRI scans without contrast dye. It will enroll 30,000 women in China to test if this safer, more accessible method is as accurate as current techniques. The goal is to create a better screening option, especially for women with dense breast tissue where traditional mammograms are less effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AI (ARTIFICIAL INTELLIGENCE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.